These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15587378)

  • 1. [Osteogenesis imperfecta as an interdisciplinary medical problem].
    Popko J; Galicka A; Wołczyński S; Zalewski W; Konstantynowicz J
    Chir Narzadow Ruchu Ortop Pol; 2004; 69(4):235-9. PubMed ID: 15587378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
    Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review.
    Sinikumpu JJ; Ojaniemi M; Lehenkari P; Serlo W
    Injury; 2015 Aug; 46(8):1440-6. PubMed ID: 25943292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
    Letocha AD; Cintas HL; Troendle JF; Reynolds JC; Cann CE; Chernoff EJ; Hill SC; Gerber LH; Marini JC
    J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL; Lund AM
    J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta: practical treatment guidelines.
    Antoniazzi F; Mottes M; Fraschini P; Brunelli PC; Tatò L
    Paediatr Drugs; 2000; 2(6):465-88. PubMed ID: 11127846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts.
    Fraser J; Lancaster GA; Scriver CR
    Connect Tissue Res; 1983; 11(1):57-67. PubMed ID: 6221880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.
    Land C; Rauch F; Munns CF; Sahebjam S; Glorieux FH
    Bone; 2006 Oct; 39(4):901-6. PubMed ID: 16730480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of bisphosphonate treatment on the radiological features of osteogenesis imperfecta in children].
    Chigladze TT; Zhvaniia MA; Bekua MV
    Georgian Med News; 2006 Feb; (131):62-5. PubMed ID: 16575136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS; Glorieux FH; Rauch F
    Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteogenesis imperfecta: contribution to pathobiochemistry].
    Pontz BF; Müller PK
    Padiatr Padol; 1984; 19(4):365-70. PubMed ID: 6504544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominantly inherited osteogenesis imperfecta in man: an examination of collagen biosynthesis.
    Lancaster G; Goldman H; Scriver CR; Gold RJ; Wong I
    Pediatr Res; 1975 Feb; 9(2):83-8. PubMed ID: 1118195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.
    Kirsch E; Krieg T; Nerlich A; Remberger K; Meinecke P; Kunze D; Müller PK
    Calcif Tissue Int; 1987 Jul; 41(1):11-7. PubMed ID: 3113698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous pamidronate treatment in children with osteogenesis imperfecta.
    Atta I; Iqbal F; Lone SW; Ibrahim M; Khan YN; Raza J
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):653-7. PubMed ID: 25233970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of collagen synthesis and structure in the differentiation of child abuse from osteogenesis imperfecta.
    Steiner RD; Pepin M; Byers PH
    J Pediatr; 1996 Apr; 128(4):542-7. PubMed ID: 8618190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.